Evidence map›Paper›PMID 23235743›Full record

ArticleMucosal immunology2013

Retinoic acid regulates the development of a gut-homing precursor for intestinal dendritic cells.

R Zeng, C Oderup, R Yuan, M Lee, A Habtezion, H Hadeiba, E C Butcher

Open access · bronzeAbstract read
In one paragraph

Article in Mucosal immunology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 103 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. A novelDiscovery immunology · 2023
    Article
  15. Review
  16. Mucosal Immunity and the Gut-Microbiota-Brain-Axis in Neuroimmune Disease.International journal of molecular sciences · 2022
    Review
  17. Review
  18. Review
  19. Article
  20. Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

R ZengLaboratory of Immunology and Vascular Biology, Department of Pathology, Stanford University School of Medicine, Stanford, California, USA. ruizhuz@stanford.edu
C Oderup
R Yuan
M Lee
A Habtezion
H Hadeiba
E C Butcher
Palo Alto Veterans Institute for Research · USStanford University · USVA Palo Alto Health Care System · US

Funding

MOLECULAR &CELLULAR IMMUNOBIOLOGYT32AI007290 · NIAID · STANFORD UNIVERSITY · PI Sean Curtis Bendall, Olivia M Martinez · 1985 to 2026
$27.0M
Proteomics/GenomicsP30DK056339 · NIDDK · STANFORD UNIVERSITY · PI GREENBERG, HARRY BERNARD · 2001 to 2010
$10.4M
Intestinal Lymphocyte TraffickingR01AI047822 · NIAID · STANFORD UNIVERSITY · PI EUGENE C BUTCHER · 2001 to 2026
$4.7M
Intestinal Lymphocyte TraffickingR37AI047822 · NIAID · PALO ALTO VETERANS INSTIT FOR RESEARCH · PI BUTCHER, EUGENE C · 2011 to 2020
$3.5M
Novel Mucosa-homing Dendritic Cell: Development, Trafficking and FunctionR01AI093981 · NIAID · PALO ALTO VETERANS INSTIT FOR RESEARCH · PI BUTCHER, EUGENE C · 2012 to 2016
$1.8M
A Novel Tolergenic Dendritic Cell: Biology & Therapeutic PotentialR01DK084647 · NIDDK · PALO ALTO VETERANS INSTIT FOR RESEARCH · PI BUTCHER, EUGENE C · 2009 to 2013
$1.5M
CCR9 AND TECK IN INTESTINAL LYMPHOCYTE TRAFFICKINGR21AI047822 · NIAID · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI BUTCHER, EUGENE C · 2000 to 2000
$258k
Trafficking mechanisms of locally generated colon antigen reactive T cellsR03DK085426 · NIDDK · STANFORD UNIVERSITY · PI HABTEZION, AIDA · 2010 to 2011
$143k
NIAID NIH HHS 5 T32 AI07290NIAID NIH HHS AI047822NIAID NIH HHS AI093981NIAID NIH HHS R01 AI047822NIAID NIH HHS R01 AI093981NIAID NIH HHS R21 AI047822NIAID NIH HHS R37 AI047822NIAID NIH HHS T32 AI007290NIDDK NIH HHS DK056339NIDDK NIH HHS DK084647NIDDK NIH HHS DK085426NIDDK NIH HHS P30 DK056339NIDDK NIH HHS R01 DK084647NIDDK NIH HHS R03 DK085426
6 · The paper itself

Abstract

The vitamin A metabolite retinoic acid (RA) regulates intestinal immune responses through immunomodulatory actions on intestinal dendritic cells (DCs) and lymphocytes. Here, we show that RA also controls the generation of gut-tropic migratory DC precursors, referred to as pre-mucosal DCs (pre-μDCs). Pre-μDCs express the gut trafficking receptor α4β7 and home preferentially to the intestines. They develop in the bone marrow (BM), can differentiate into CCR9⁺ plasmacytoid DCs as well as conventional DCs (cDCs), but preferentially give rise to CD103⁺ intestinal cDCs. Generation of pre-μDCs in vivo in the BM or in vitro is regulated by RA and RA receptor α (RARα) signaling. The frequency of pre-μDCs is reduced in vitamin A-deficient animals and in animals treated with RAR inhibitors. The results define a novel vitamin A-dependent, RA-regulated developmental sequence for DCs and identify a targeted precursor for CD103⁺ cDCs in the gut.

Indexed as

AnimalsAntigens, CDBone Marrow CellsCell DifferentiationDendritic CellsImmunologic FactorsImmunophenotypingIntegrin alpha4Integrin alpha ChainsIntestinal MucosaMicePeyer's PatchesPhenotypeReceptors, CCRStem CellsTretinoinalpha E integrinsAntigens, CDCC chemokine receptor 9Immunologic FactorsIntegrin alpha4Integrin alpha ChainsReceptors, CCRTretinoin

Identifiers

PMID23235743
PMCPMC3612556
OpenAlexW2004950298

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.